Pacific Edge Ltd (PEB)

Currency in NZD
0.1820
-0.0020(-1.09%)
Closed·
PEB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.18200.1860
52 wk Range
0.06000.2250
Key Statistics
Bid/Ask
0.182 / 0.185
Prev. Close
0.182
Open
0.184
Day's Range
0.182-0.186
52 wk Range
0.06-0.225
Volume
389.62K
Average Volume (3m)
644.98K
1-Year Change
198.3607%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PEB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.1600
Downside
-12.09%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Pacific Edge Company Profile

Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up for patients with haematuria who have a low probability of bladder cancer; and Cxbladder Monitor, a non-invasive surveillance alternative that reduces the burden of repeated cystoscopy in patients with a low risk of recurrence. In addition, the company is developing products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.

Compare PEB to Peers and Sector

Metrics to compare
PEB
Peers
Sector
Relationship
P/E Ratio
−5.4x−2.8x−0.6x
PEG Ratio
0.35−0.080.00
Price/Book
7.0x2.7x2.6x
Price / LTM Sales
10.3x14.6x3.3x
Upside (Analyst Target)
−12.1%128.0%45.0%
Fair Value Upside
Unlock5.4%6.5%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.1600
(-12.09% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 24, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
6.84M / --
EPS Revisions
Last 90 days

FAQ

What Is the Pacific Edge (PEB) Share Price Today?

The live Pacific Edge share price today is 0.1820

What Stock Exchange Does Pacific Edge (PEB) Trade On?

Pacific Edge is listed and trades on the New Zealand Exchange.

What Is the Ticker (Stock Symbol) for Pacific Edge?

The stock symbol (also called a 'ticker') for Pacific Edge is "PEB."

What Is the Current Pacific Edge Market Cap?

As of today, Pacific Edge market capitalisation is 186.11M.

What Is Pacific Edge's (PEB) Earnings Per Share (TTM)?

The Pacific Edge EPS is currently -0.04 (Trailing Twelve Months).

When Is the Next Pacific Edge Earnings Date?

Pacific Edge's next earnings report will be released on 25 Feb 2026.

Is PEB a Buy or Sell From a Technical Analyst Perspective?

Based on today's Pacific Edge moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Pacific Edge Stock Split?

Pacific Edge has split 5 times. (See the PEB stock split history page for full effective split date and price information.)

How Many Employees Does Pacific Edge Have?

Pacific Edge has 114 employees.

What is the current trading status of Pacific Edge (PEB)?

As of 04 Feb 2026, Pacific Edge (PEB) is trading at a price of 0.1820, with a previous close of 0.1820. The stock has fluctuated within a day range of 0.1820 to 0.1860, while its 52-week range spans from 0.0600 to 0.2250.

What Is Pacific Edge (PEB) Price Target According to Analysts?

The average 12-month price target for Pacific Edge is NZD0.1600, with a high estimate of NZD0.16 and a low estimate of NZD0.16. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -12.09% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.